Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article
Advertisement

ResearchIn-Press PreviewDevelopmentNephrologyOncology Open Access | 10.1172/jci.insight.188078

Single nuclei RNA-sequencing reveals transcriptional heterogeneity in the blastema of favorable histology Wilms tumor

Mike Adam,1 Keri A. Drake,2 Naomi Pode-Shakked,3 Katherine VandenHeuvel,4 Steve Potter,5 and James Geller6

1Division of Experimental Hematology and Cancer Biology, Cancer and Blood Di, Cincinnati Children’s Hospital Medical Center, Cincinnati, United States of America

2Division of Pediatric Nephrology, University of Texas Southwestern Medical Center, Dallas, United States of America

3Pediatric Nephrology Unit, Dana Dwek Children’s Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

4Division of Pathology and Laboratory Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America

5Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America

6Division of Hematology/Oncology, Department of Pediatrics, Peckham Center for Cancer and Blood Disorders, Rady Children’s Hospital, San Diego, United States of America

Find articles by Adam, M. in: PubMed | Google Scholar

1Division of Experimental Hematology and Cancer Biology, Cancer and Blood Di, Cincinnati Children’s Hospital Medical Center, Cincinnati, United States of America

2Division of Pediatric Nephrology, University of Texas Southwestern Medical Center, Dallas, United States of America

3Pediatric Nephrology Unit, Dana Dwek Children’s Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

4Division of Pathology and Laboratory Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America

5Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America

6Division of Hematology/Oncology, Department of Pediatrics, Peckham Center for Cancer and Blood Disorders, Rady Children’s Hospital, San Diego, United States of America

Find articles by Drake, K. in: PubMed | Google Scholar

1Division of Experimental Hematology and Cancer Biology, Cancer and Blood Di, Cincinnati Children’s Hospital Medical Center, Cincinnati, United States of America

2Division of Pediatric Nephrology, University of Texas Southwestern Medical Center, Dallas, United States of America

3Pediatric Nephrology Unit, Dana Dwek Children’s Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

4Division of Pathology and Laboratory Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America

5Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America

6Division of Hematology/Oncology, Department of Pediatrics, Peckham Center for Cancer and Blood Disorders, Rady Children’s Hospital, San Diego, United States of America

Find articles by Pode-Shakked, N. in: PubMed | Google Scholar

1Division of Experimental Hematology and Cancer Biology, Cancer and Blood Di, Cincinnati Children’s Hospital Medical Center, Cincinnati, United States of America

2Division of Pediatric Nephrology, University of Texas Southwestern Medical Center, Dallas, United States of America

3Pediatric Nephrology Unit, Dana Dwek Children’s Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

4Division of Pathology and Laboratory Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America

5Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America

6Division of Hematology/Oncology, Department of Pediatrics, Peckham Center for Cancer and Blood Disorders, Rady Children’s Hospital, San Diego, United States of America

Find articles by VandenHeuvel, K. in: PubMed | Google Scholar

1Division of Experimental Hematology and Cancer Biology, Cancer and Blood Di, Cincinnati Children’s Hospital Medical Center, Cincinnati, United States of America

2Division of Pediatric Nephrology, University of Texas Southwestern Medical Center, Dallas, United States of America

3Pediatric Nephrology Unit, Dana Dwek Children’s Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

4Division of Pathology and Laboratory Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America

5Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America

6Division of Hematology/Oncology, Department of Pediatrics, Peckham Center for Cancer and Blood Disorders, Rady Children’s Hospital, San Diego, United States of America

Find articles by Potter, S. in: PubMed | Google Scholar

1Division of Experimental Hematology and Cancer Biology, Cancer and Blood Di, Cincinnati Children’s Hospital Medical Center, Cincinnati, United States of America

2Division of Pediatric Nephrology, University of Texas Southwestern Medical Center, Dallas, United States of America

3Pediatric Nephrology Unit, Dana Dwek Children’s Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

4Division of Pathology and Laboratory Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America

5Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America

6Division of Hematology/Oncology, Department of Pediatrics, Peckham Center for Cancer and Blood Disorders, Rady Children’s Hospital, San Diego, United States of America

Find articles by Geller, J. in: PubMed | Google Scholar

Published June 9, 2026 - More info

JCI Insight. https://doi.org/10.1172/jci.insight.188078.
Copyright © 2026, Adam et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published June 9, 2026 - Version history
View PDF
Abstract

While Wilms tumors commonly arise from renal precursor cells and maintain features of the developing kidney, recent studies have demonstrated significant genetic, histologic, and molecular heterogeneity. To further investigate tumor variability as well as unifying features in tumor biology, we performed single nuclei RNA-sequencing (snRNA-seq) on treatment naïve, favorable histology Wilms tumors utilizing a reference atlas established from tumor-adjacent kidney samples and fetal kidney. Transcriptional profiles of blastemal, stromal, and epithelial components were correlated with tumor histology and demonstrate developmental-lineage plasticity, with PAX2 and PAX8 expression normally restricted to the nephron lineage of the fetal kidney found to be expressed in tumor stroma, as well as the stromal marker POSTN identified in tumor blastema. Further analyses of the blastema show shared transcriptional features with the differentiation trajectory of “uninduced” to “early differentiating” fetal nephron progenitor cells as well as aberrant expression of stromal signatures. A number of pathways from fetal nephron progenitors were maintained in the blastema, including regulation of stem cell maintainence and axonogenesis, whereas other pathways appear enriched in specific tumor samples, demonstrating the ability of snRNA-seq to identify both unifiying transcriptional signatures and uncover distinct molecular targets in signaling pathways and/or biological drivers of Wilms tumorigenesis.

Graphical Abstract
graphical abstract
Supplemental material

View Supplemental File S1

View Supplemental File S2

View Supplemental File S3

View Supplemental File S5

View Supplemental Tables S1 and S2

View Supplemental File S4

View Supplemental File S5

Version history
  • Version 1 (June 9, 2026): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts